CNPFX
Price
$64.52
Change
+$0.06 (+0.09%)
Updated
May 22 closing price
Net Assets
147.5B
MWOGX
Price
$47.62
Change
+$0.02 (+0.04%)
Updated
May 22 closing price
Net Assets
912.78M
Interact to see
Advertisement

CNPFX vs MWOGX

Header iconCNPFX vs MWOGX Comparison
Open Charts CNPFX vs MWOGXBanner chart's image
American Funds New Perspective 529F
Price$64.52
Change+$0.06 (+0.09%)
VolumeN/A
Net Assets147.5B
MFS Global Growth R1
Price$47.62
Change+$0.02 (+0.04%)
VolumeN/A
Net Assets912.78M
CNPFX vs MWOGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNPFX vs. MWOGX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Buy and MWOGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 148B vs. MWOGX (913M). CNPFX pays higher dividends than MWOGX: CNPFX (0.73) vs MWOGX (0.00). CNPFX was incepted earlier than MWOGX: CNPFX (23 years) vs MWOGX (20 years). MWOGX (2.07) is less costly to investors than CNPFX (0.84). CNPFX (24.00) and MWOGX (24.00) have comparable annual turnover. MWOGX has a lower initial minimum investment than CNPFX: MWOGX (0) vs CNPFX (250). CNPFX annual gain was more profitable for investors over the last year : 7.60 vs. MWOGX (-4.67). CNPFX return over 5 years is better than : 52.47 vs. MWOGX (26.87).
CNPFXMWOGXCNPFX / MWOGX
Total Expense Ratio0.841.9743%
Annual Report Gross Expense Ratio0.842.0741%
Fund Existence23 years20 years-
Gain YTD6.293-0.084-7,495%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets148B913M16,210%
Annual Yield % from dividends0.730.00-
Returns for 1 year7.60-4.67-163%
Returns for 3 years32.0611.66275%
Returns for 5 years52.4726.87195%
Returns for 10 years79.7749.59161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.420.01
+3.02%
Lyell Immunopharma
MTNB0.77N/A
N/A
Matinas Biopharma Holdings Inc
BE18.21N/A
N/A
Bloom Energy Corp
TRVI6.18N/A
N/A
Trevi Therapeutics
EMN81.36-0.12
-0.15%
Eastman Chemical Company